🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of nirapar...
Status
Completed
Location
Aichi Cancer Center Hospital
Start Date
2018-12-26
Trial ID
NCT03759600
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety, and pharmacoki...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-31
Trial ID
NCT02854436
Treatments Being Tested
Multicentre, 2 arm, open-label UK randomised phase II trial to determine th...
Status
Completed
Location
University Hospital Southampton, Southampton General Hospital
Start Date
2022-07-11
Trial ID
NCT05455424
Treatments Being Tested
This is a phase I/II study to preliminarily explore of the safety, tolerabi...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-07-10
Trial ID
NCT06953323
Ovarian cancer is a heterogeneous disease, characterized by complex molecul...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2018-10-11
Trial ID
NCT03602859
Treatments Being Tested
This research is being done to see how effective the drug niraparib is agai...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2022-04-05
Trial ID
NCT04992013
Treatments Being Tested
The main aim of this study is to check for side effects from treatment with...
Status
Completed
Location
Takeda Selected Site
Start Date
2021-09-13
Trial ID
NCT05021562
Treatments Being Tested
This is a multicenter, open-label, phase 2 study to evaluate the efficacy a...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-29
Trial ID
NCT03308942
Treatments Being Tested
The objective of REVOCAN study is to assess the abrogation of PARP inhibito...
Status
Terminated
Location
CHU Jean Minjoz
Start Date
2020-10-05
Trial ID
NCT04826198
ProBio is an international, outcome-adaptive, multi-arm, open-label, multip...
Status
Recruiting
Location
OLV Ziekenhuis Aalst
Start Date
2019-02-01
Trial ID
NCT03903835